Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OAK: ASP7962 in Osteoarthritis of the Knee
NCT02611466Phase 2Completed
- Sponsor
- Astellas Pharma
- Start
- Feb 2016
- Primary completion
- Aug 2017
- Modality
- Small Molecules
- Countries
- 6
01
Overview
A Phase 2 trial of ASP7962 in knee osteoarthritis (OA), sponsored by Astellas Pharma. Started Feb 2016; status: completed.
02
Drugs
ASP7962
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on NCT02611466.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02611466.